Antares Pharma Overview

Antares Pharma Cost of Revenue

Cost of Revenue analysis for ATRS.

Quarterly Cost of Revenue

$18.77M

↑ 14.12% YoY

As of Mar 31, 2022

Annual Cost of Revenue (TTM)

$70.60M

↑ 9.47% YoY

Trailing 12 months ending Mar 31, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin